Our study demonstrates that ADAM17 regulates ferroptosis in lung fibroblasts to promote fibrosis development through PTGS2, suggesting a potential therapeutic target in ADAM17 for the treatment of lung fibrosis. This evidence concerns the gene PTGS2 and pulmonary fibrosis.